PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 2.92M (Avg.)
-0.48 | -4.19
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
18.13%
Growth of 18.13% versus flat Healthcare revenue. Walter Schloss would verify growth quality.
-2.23%
Cost reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive advantage potential.
126.49%
Growth of 126.49% versus flat Healthcare gross profit. Walter Schloss would verify quality.
91.73%
Margin change of 91.73% versus flat Healthcare margins. Walter Schloss would verify quality.
119.27%
R&D change of 119.27% versus flat Healthcare spending. Walter Schloss would verify adequacy.
50.66%
G&A change of 50.66% versus flat Healthcare overhead. Walter Schloss would verify efficiency.
-5.36%
Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-101.65%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
49.22%
Operating expenses growth while Healthcare reduces costs. Peter Lynch would examine differences.
15.49%
Total costs growth while Healthcare reduces costs. Peter Lynch would examine differences.
-12.53%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
144.30%
D&A change of 144.30% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
-43.69%
EBITDA decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-361.27%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
7.01%
Operating income growth exceeding 1.5x Healthcare median of 0.84%. Joel Greenblatt would investigate advantages.
21.28%
Margin change of 21.28% versus flat Healthcare. Walter Schloss would verify quality.
-119.25%
Other expenses reduction while Healthcare median is 2.88%. Seth Klarman would investigate advantages.
-177.82%
Pre-tax income decline while Healthcare median is 0.55%. Seth Klarman would investigate causes.
-165.87%
Pre-tax margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
0.38%
Tax expense growth below 50% of Healthcare median of 0.95%. Joel Greenblatt would investigate efficiency.
-223.94%
Net income decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-204.92%
Net margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-151.50%
EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-151.50%
Diluted EPS decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
0.66%
Share count reduction below 50% of Healthcare median of 0.25%. Jim Chanos would check for issues.
0.66%
Diluted share reduction below 50% of Healthcare median of 0.17%. Jim Chanos would check for issues.